Rural Health
Resources by Topic: Pharmacy and prescription drugs
Locations and Characteristics of Pharmacy Deserts in the United States: A Geospatial Study
Classifies census tracts as pharmacy deserts or non-pharmacy deserts. Compares pharmacy desert and non-pharmacy desert areas by various social determinants of health and pharmacy characteristics including rurality. See the supplemental materials for state-by-state and rural/urban comparisons.
Author(s): Rachel Wittenauer, Parth D. Shah, Jennifer L. Bacci, Andy Stergachis
Citation: Health Affairs Scholar, 2(4)
Date: 04/2024
view details
Classifies census tracts as pharmacy deserts or non-pharmacy deserts. Compares pharmacy desert and non-pharmacy desert areas by various social determinants of health and pharmacy characteristics including rurality. See the supplemental materials for state-by-state and rural/urban comparisons.
Author(s): Rachel Wittenauer, Parth D. Shah, Jennifer L. Bacci, Andy Stergachis
Citation: Health Affairs Scholar, 2(4)
Date: 04/2024
view details
Federal Retail Pharmacy Program Contributions to Bivalent mRNA COVID-19 Vaccinations Across Sociodemographic Characteristics — United States, September 1, 2022–September 30, 2023
Reports on COVID-19 bivalent vaccine doses administered by pharmacies participating in the Federal Retail Pharmacy Program (FRPP) from September 1, 2022–September 30, 2023. Includes data on doses administered in urban and rural settings and discusses urban compared to rural contributions of FRPP pharmacies.
Author(s): Roua El Kalach, Nkenge Jones-Jack, Mattie A. Elam, et al.
Citation: MMWR (Morbidity and Mortality Weekly Report), 73(13), 286-290
Date: 04/2024
Sponsoring organization: Centers for Disease Control and Prevention
view details
Reports on COVID-19 bivalent vaccine doses administered by pharmacies participating in the Federal Retail Pharmacy Program (FRPP) from September 1, 2022–September 30, 2023. Includes data on doses administered in urban and rural settings and discusses urban compared to rural contributions of FRPP pharmacies.
Author(s): Roua El Kalach, Nkenge Jones-Jack, Mattie A. Elam, et al.
Citation: MMWR (Morbidity and Mortality Weekly Report), 73(13), 286-290
Date: 04/2024
Sponsoring organization: Centers for Disease Control and Prevention
view details
The 340B Drug Pricing Program: A Small Part of the Prescription Drug Market, Delivering Large Benefits to Patients and Communities
Analyzes impacts of the 340B Drug Pricing Program on access, hospital finance, drug companies, and public expenditures. Discusses how the 340B program is shaped by legislation, policy, finance, prescribing patterns, and market influences. Highlights rural and underserved communities throughout.
Date: 03/2024
Sponsoring organization: American Hospital Association
view details
Analyzes impacts of the 340B Drug Pricing Program on access, hospital finance, drug companies, and public expenditures. Discusses how the 340B program is shaped by legislation, policy, finance, prescribing patterns, and market influences. Highlights rural and underserved communities throughout.
Date: 03/2024
Sponsoring organization: American Hospital Association
view details
Generic Drug Utilization and Spending Among Medicare Part D Enrollees in 2022
Issue brief on prescriptions for generic drugs filled by Medicare Part D enrollees using 2022 Part D prescription drug event (PDE) data. Covers commonly used prescription drugs, costs, and conditions treated, and includes data breakdowns by plan type, race and ethnicity, and level of rurality throughout. Discusses formulary design to improve access by promoting affordability and reducing confusion among enrollees.
Author(s): Yevgeniy Feyman, Bisma Sayed, Kenneth Finegold, et al.
Date: 03/2024
Sponsoring organization: HHS Office of the Assistant Secretary for Planning and Evaluation
view details
Issue brief on prescriptions for generic drugs filled by Medicare Part D enrollees using 2022 Part D prescription drug event (PDE) data. Covers commonly used prescription drugs, costs, and conditions treated, and includes data breakdowns by plan type, race and ethnicity, and level of rurality throughout. Discusses formulary design to improve access by promoting affordability and reducing confusion among enrollees.
Author(s): Yevgeniy Feyman, Bisma Sayed, Kenneth Finegold, et al.
Date: 03/2024
Sponsoring organization: HHS Office of the Assistant Secretary for Planning and Evaluation
view details
Inflation Reduction Act Research Series: Projected Impacts for Rural Medicare Enrollees
Provides an overview of how the Inflation Reduction Act (IRA) is intended to improve prescription drug affordability for Medicare enrollees. Describes Medicare enrollment in rural areas and rural residents' health status and access to care. Outlines the projected impact of drug-related IRA provisions for rural Medicare beneficiaries, including the expansion of financial assistance through the low-income subsidy program, out-of-pocket spending caps for insulin, changes in Part D benefit design, and more.
Date: 03/2024
Sponsoring organization: HHS Office of the Assistant Secretary for Planning and Evaluation
view details
Provides an overview of how the Inflation Reduction Act (IRA) is intended to improve prescription drug affordability for Medicare enrollees. Describes Medicare enrollment in rural areas and rural residents' health status and access to care. Outlines the projected impact of drug-related IRA provisions for rural Medicare beneficiaries, including the expansion of financial assistance through the low-income subsidy program, out-of-pocket spending caps for insulin, changes in Part D benefit design, and more.
Date: 03/2024
Sponsoring organization: HHS Office of the Assistant Secretary for Planning and Evaluation
view details
What Does Pharmacy Access Look like in Your Area?
Interactive map showing the number of pharmacies and pharmacies per 1,000 people at the state and county level. Includes the option to view pharmacy access by demographic variables.
Date: 02/2024
Sponsoring organization: The Associated Press
view details
Interactive map showing the number of pharmacies and pharmacies per 1,000 people at the state and county level. Includes the option to view pharmacy access by demographic variables.
Date: 02/2024
Sponsoring organization: The Associated Press
view details
Telemedicine vs Telephone Consultations and Medication Prescribing Errors Among Referring Physicians: A Cluster Randomized Crossover Trial
Compared 696 acutely ill children in 15 community and rural California emergency departments receiving telephone or video consultations to determine differences in physician-related medication errors. Discusses the impact of telehealth on healthcare quality and remote acute care.
Author(s): James P. Marcin, Monica K. Lieng, Jamie Mouzoon, et al.
Citation: JAMA Network Open, 7(2)
Date: 02/2024
view details
Compared 696 acutely ill children in 15 community and rural California emergency departments receiving telephone or video consultations to determine differences in physician-related medication errors. Discusses the impact of telehealth on healthcare quality and remote acute care.
Author(s): James P. Marcin, Monica K. Lieng, Jamie Mouzoon, et al.
Citation: JAMA Network Open, 7(2)
Date: 02/2024
view details
Hearing on Examining Chronic Drug Shortages in the United States
Congressional hearing in the U.S. House of Representatives Ways & Means Committee discussing pharmaceutical drug shortages. Discusses cancer care, healthcare quality, the 340B program, supply and demand, reimbursement, and other policy measures. Witnesses include Dr. Stephen Schleicher discussing rural concerns. Captions available in video player.
Additional links: Dr. Stephen Schleicher Testimony
Date: 02/2024
Sponsoring organization: House Ways and Means Committee
view details
Congressional hearing in the U.S. House of Representatives Ways & Means Committee discussing pharmaceutical drug shortages. Discusses cancer care, healthcare quality, the 340B program, supply and demand, reimbursement, and other policy measures. Witnesses include Dr. Stephen Schleicher discussing rural concerns. Captions available in video player.
Additional links: Dr. Stephen Schleicher Testimony
Date: 02/2024
Sponsoring organization: House Ways and Means Committee
view details
Testing the Feasibility of the QuitAid Smoking Cessation Intervention in a Randomized Factorial Design in an Independent, Rural Community Pharmacy
Examines a pharmacist-delivered smoking cessation intervention in rural Appalachia. Analyzes an ask-advise-connect model conducted with 24 adult smokers between September and November 2021, observing recruitment, retention, treatment adherence, and fidelity. Includes data on participant demographics, participant satisfaction, and pharmacist perceptions.
Author(s): Melissa A. Little, Taylor Reid, Matthew Moncrief, et al.
Citation: Pilot and Feasibility Studies, 10(41)
Date: 02/2024
view details
Examines a pharmacist-delivered smoking cessation intervention in rural Appalachia. Analyzes an ask-advise-connect model conducted with 24 adult smokers between September and November 2021, observing recruitment, retention, treatment adherence, and fidelity. Includes data on participant demographics, participant satisfaction, and pharmacist perceptions.
Author(s): Melissa A. Little, Taylor Reid, Matthew Moncrief, et al.
Citation: Pilot and Feasibility Studies, 10(41)
Date: 02/2024
view details
Beneficiary and Clinician Perspectives on Medicare and Other Issues: Findings from 2023 Focus Groups in Select States
Summarizes findings from 24 focus groups of Medicare beneficiaries, Medicare and Medicaid (dual eligible) beneficiaries, and clinicians conducted between May and July 2023, including three virtual focus groups of rural Medicare beneficiaries. Highlights themes that emerged across the focus groups covering Medicare coverage options, access to care, telehealth, organization of care, and prescription drugs.
Date: 02/2024
Sponsoring organizations: Medicare Payment Advisory Commission, NORC at the University of Chicago
view details
Summarizes findings from 24 focus groups of Medicare beneficiaries, Medicare and Medicaid (dual eligible) beneficiaries, and clinicians conducted between May and July 2023, including three virtual focus groups of rural Medicare beneficiaries. Highlights themes that emerged across the focus groups covering Medicare coverage options, access to care, telehealth, organization of care, and prescription drugs.
Date: 02/2024
Sponsoring organizations: Medicare Payment Advisory Commission, NORC at the University of Chicago
view details